Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Clin Pharmacol Ther ; 103(3): 502-510, 2018 03.
Article in English | MEDLINE | ID: mdl-28597911

ABSTRACT

High-resolution measurement of medication adherence is essential to personalized drug therapy. A US Food and Drug Administration (FDA)-cleared device, using an edible ingestion sensor (IS), external wearable patch, and paired mobile device can detect and record ingestion events. Oral medications must be combined with an IS to generate precise "digitized-medication" ingestion records. We developed a Good Manufacturing Practice protocol to repackage oral medications with the IS within certified Capsugel capsules, termed co-encapsulation (CoE). A randomized bioequivalence study of CoE-IS-Rifamate (Isoniazid/Rifampin 150/300 mg) vs. native-Rifamate was conducted in 12 patients with active Mycobacterium tuberculosis and demonstrated bioequivalence using the population method ratio test (95% confidence interval). Subsequently, CoE-IS-medications across all biopharmaceutical classes underwent in vitro dissolution testing utilizing USP and FDA guidelines. CoE-IS medications tested met USP dissolution specifications and were equivalent to their native formulations. CoE combines oral medications with the IS without altering the quality of the native formulation, generating "digitized" medications for remote capture of dosing histories.


Subject(s)
Capsules , Drug Combinations , Medication Adherence/statistics & numerical data , Telemedicine/methods , Antihypertensive Agents/administration & dosage , Antihypertensive Agents/therapeutic use , Antitubercular Agents/administration & dosage , Cross-Over Studies , Drug Therapy/methods , Electronics , Glipizide/administration & dosage , Glipizide/therapeutic use , Humans , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/therapeutic use , Hypolipidemic Agents/administration & dosage , Hypolipidemic Agents/therapeutic use , Mobile Applications , Precision Medicine , Solubility , Therapeutic Equivalency
2.
Waste Manag ; 28(7): 1219-26, 2008.
Article in English | MEDLINE | ID: mdl-17651963

ABSTRACT

A comprehensive understanding of the quantities and characteristics of the material that needs to be managed is one of the most basic steps in the development of a plan for solid waste management. In this case, the material under consideration is the solid waste generated in healthcare facilities, also known as healthcare waste. Unfortunately, limited reliable information is available in the open literature on the quantities and characteristics of the various types of wastes that are generated in healthcare facilities. Thus, sound management of these wastes, particularly in developing countries, often is problematic. This article provides information on the quantities and properties of healthcare wastes in various types of facilities located in developing countries, as well as in some industrialized countries. Most of the information has been obtained from the open literature, although some information has been collected by the authors and from reports available to the authors. Only data collected within approximately the last 15 years and using prescribed methodologies are presented. The range of hospital waste generation (both infectious and mixed solid waste fractions) varies from 0.016 to 3.23kg/bed-day. The relatively wide variation is due to the fact that some of the facilities surveyed in Ulaanbaatar include out-patient services and district health clinics; these facilities essentially provide very basic services and thus the quantities of waste generated are relatively small. On the other hand, the reported amount of infectious (clinical, yellow bag) waste varied from 0.01 to 0.65kg/bed-day. The characteristics of the components of healthcare wastes, such as the bulk density and the calorific value, have substantial variability. This literature review and the associated attempt at a comparative analysis point to the need for worldwide consensus on the terms and characteristics that describe wastes from healthcare facilities. Such a consensus would greatly facilitate comparative analyses among different facilities, studies and countries.


Subject(s)
Developed Countries , Developing Countries , Medical Waste Disposal/methods , Medical Waste/analysis , Medical Waste/classification , Data Collection , Hazardous Substances , Health Facilities , Hospital Bed Capacity , Humans
3.
Waste Manag ; 25(6): 626-37, 2005.
Article in English | MEDLINE | ID: mdl-15993347

ABSTRACT

Waste production in healthcare facilities in developing countries has brought about a variety of concerns due to the use of inappropriate methods of managing the wastes. Inappropriate treatment and final disposal of the wastes can lead to adverse impacts to public health, to occupational health and safety, and to the environment. Unfortunately, most economically developing countries suffer a variety of constraints to adequately managing these wastes. Generally in developing countries, few individuals in the staff of the healthcare facility are familiar with the procedures required for a proper waste management program. Furthermore, the management of wastes usually is delegated to poorly educated laborers who perform most activities without proper guidance and insufficient protection. This paper presents some of the most common treatment and disposal methods utilized in the management of infectious healthcare wastes in developing countries. The methods discussed include: autoclave; microwave; chemical disinfection; combustion (low-, medium-, and high-technology); and disposal on the ground (dump site, controlled landfill, pits, and sanitary landfill). Each alternative for treatment and disposal is explained, including a description of the types of wastes that can and cannot be treated. Background information on the technologies also is included in order to provide information to those who may not be familiar with the details of each alternative. In addition, a brief presentation of some of the emissions from each of the treatment and disposal alternatives is presented.


Subject(s)
Developing Countries , Medical Waste Disposal/methods , Equipment Design , Humans , Technology/trends
4.
Mol Genet Metab ; 67(2): 113-7, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10356310

ABSTRACT

Erythropoietin (Epo), a glycoprotein hormone produced principally in the fetal kidney and in the adult liver in response to hypoxia, is the prime regulator of growth and differentiation in erythroid progenitor cells. The regulation of Epo gene expression is not fully understood, but two mechanisms have been proposed. One involves the participation of a heme protein capable of reversible oxygenation and the other depends on the intracellular concentration of reactive oxygen species (ROS), assumed to be a function of pO2. We have investigated the production of Epo in response to three stimuli, hypoxia, cobalt chloride, and the iron chelator desferrioxamine, in Hep3B cells. As expected, hypoxia caused a marked rise in Epo production. When the cells were exposed to the paired stimuli of hypoxia and cobalt no further increase was found. In contrast, chelation of iron under hypoxic conditions markedly enhanced Epo production, suggesting that the two stimuli act by separate pathways. The addition of carbon monoxide inhibited hypoxia-induced Epo production, independent of desferrioxamine concentration. Taken together these data support the concept that pO2 and ROS are sensed independently.


Subject(s)
Erythropoietin/biosynthesis , Erythropoietin/genetics , Gene Expression Regulation , Oxygen/metabolism , Carcinoma, Hepatocellular , Cell Hypoxia/drug effects , Cell Hypoxia/genetics , Cycloheximide/pharmacology , Deferoxamine/pharmacology , Erythropoietin/metabolism , Gene Expression Regulation/drug effects , Humans , RNA, Messenger/biosynthesis , Transcription, Genetic/drug effects , Tumor Cells, Cultured
5.
J Am Assoc Gynecol Laparosc ; 5(2): 203-6, 1998 May.
Article in English | MEDLINE | ID: mdl-9564073

ABSTRACT

Laparoscopic supracervical hysterectomy (LSH) can be performed more easily with a powered morcellator for removal of the uterus. Available laparoscopic morcellators are expensive and may be difficult to use, but a new, powered, disposable instrument was developed (Diva; FemRx, Sunnyvale, CA) to morcellate the entire uterus for easy removal through a 15-mm cannula. Twelve consecutive women for whom subtotal hysterectomy was indicated underwent LSH by standard laparoscopic protocol and were monitored postoperatively for a minimum of 1 month. In the current trend of "less is more," LSH is an emerging option for less extensive hysterectomies and can be made more cost and time effective with a single-use powered morcellator.


Subject(s)
Cervix Uteri/surgery , Hysterectomy, Vaginal/instrumentation , Laparoscopes , Leiomyomatosis/surgery , Uterine Neoplasms/surgery , Adult , Costs and Cost Analysis , Equipment Design , Equipment Safety , Female , Humans , Hysterectomy, Vaginal/methods , Laparoscopy/methods , Leiomyomatosis/diagnostic imaging , Middle Aged , Surgical Equipment/economics , Treatment Outcome , Ultrasonography , Uterine Neoplasms/diagnostic imaging
7.
Waste Manag Res ; 9(5): 389-94, 1991 Oct.
Article in English | MEDLINE | ID: mdl-11537690

ABSTRACT

Solid wastes can be processed for material and energy recovery using a number of unit operations and system approaches. The selection and configuration of unit operations and systems depends upon the characteristics of the wastes to be processed and the uses for recovered secondary materials and for recovered energy forms. The discussion focuses on the types of materials and forms of energy potentially recoverable from solid wastes, waste processing and conversion systems, and design considerations.


Subject(s)
Ecological Systems, Closed , Life Support Systems/instrumentation , Refuse Disposal/instrumentation , Refuse Disposal/methods , Spacecraft/instrumentation , Air Conditioning/methods , Cellulose, Oxidized , Conservation of Natural Resources , Energy-Generating Resources , Ethanol , Paper , Space Flight/instrumentation , Weightlessness
SELECTION OF CITATIONS
SEARCH DETAIL